Steven Cohen’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-300,000
Closed -$25.5M 1239
2020
Q3
$25.5M Sell
300,000
-4,057,664
-93% -$205M 0.13% 218
2020
Q2
$154M Buy
4,357,664
+858,690
+25% +$25.1M 1.01% 7
2020
Q1
$47.2M Buy
+3,498,974
New +$58.9M 0.38% 62
2019
Q2
Sell
-34,300
Closed -$659K 1633
2019
Q1
$659K Sell
34,300
-1,088,900
-97% -$17.6M ﹤0.01% 855
2018
Q4
$16M Buy
1,123,200
+185,659
+20% +$3.69M 0.08% 306
2018
Q3
$19.5M Buy
937,541
+107,805
+13% +$2.55M 0.08% 305
2018
Q2
$19.6M Buy
829,736
+380,516
+85% +$7.65M 0.08% 309
2018
Q1
$6.56M Buy
449,220
+32,688
+8% +$534K 0.03% 517
2017
Q4
$6.73M Buy
+416,532
New +$4.92M 0.03% 532
2017
Q2
Sell
-1,195,613
Closed -$7.74M 1070
2017
Q1
$7.74M Buy
1,195,613
+1,127,213
+1,648% +$5.71M 0.04% 446
2016
Q4
$251K Buy
+68,400
New +$202K ﹤0.01% 649

Steven Cohen's IMMU Position: Q4 2020 in Review

Steven Cohen sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 300,000 shares — an estimated $25.5M sold.

Steven Cohen first reported a position in IMMU in Q4 2016 and held it in 11 quarters. The position peaked at $154M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Steven Cohen reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Steven Cohen sold 300,000 Immunomedics Inc shares in Q4 2020, an estimated $25.5M.
  • Steven Cohen first reported a position in Immunomedics Inc in Q4 2016 and held it in 11 quarters.
  • Steven Cohen's Immunomedics Inc position peaked at $154M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Point72 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.